Norepinephrine: the redheaded stepchild of Parkinson's disease
KS Rommelfanger, D Weinshenker - Biochemical pharmacology, 2007 - Elsevier
Parkinson's disease (PD) affects approximately 1% of the world's aging population. Despite
its prevalence and rigorous research in both humans and animal models, the etiology …
its prevalence and rigorous research in both humans and animal models, the etiology …
Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection
D Stephenson, A Ramirez, J Long, N Barrezueta… - Journal of neuroscience …, 2007 - Elsevier
The neurotoxin MPTP is widely used to cause damage to the dopaminergic system in
rodents and non-human primates to model various aspects of Parkinson's disease. In mice …
rodents and non-human primates to model various aspects of Parkinson's disease. In mice …
Glial reaction in Parkinson's diseases: inflammatory activation signaling of glia as a potential therapeutic target
Although the main cause of many neurodegenerative diseases is unknown, the glial
reaction is considered to be a consequence of neuronal cell death in Alzheimer's disease …
reaction is considered to be a consequence of neuronal cell death in Alzheimer's disease …
The MPTP Model of Parkinson's Disease
S Przedborski - Parkinson's Disease, 2007 - taylorfrancis.com
In his monograph “The case of the frozen addicts,” William Langston reported the story of six
patients, who, in 1982, in California, developed mysterious symptoms provoked by 1-methyl …
patients, who, in 1982, in California, developed mysterious symptoms provoked by 1-methyl …